Replidyne Plans To File Faropenem Antibacterial NDA In 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Faropenem has broad spectrum of activity similar to quinolone class of antibiotics with safety profile comparable to beta-lactam antibiotics, company says. Product was developed by Bayer but divested under R&D restructuring in 2002.